Analystreport

Millendo Therapeutics Inc (NASDAQ: MLND) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating on the stock.

Millendo Therapeutics, Inc. - Common Stock  (MLND) 
Last millendo therapeutics, inc. - common stock earnings: 11/13 08:30 am Check Earnings Report